John W. Smither, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 5,000 shares at $35.00 ($175K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $175k ARQT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 1,250 | $44K | 25.0% |
| 2 | $35.00 | 3,750 | $131K | 75.0% |
| Total | $35.00 avg | 5,000 | $175K | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |